These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 25385736)
1. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736 [TBL] [Abstract][Full Text] [Related]
2. Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines. Saleh RR; Majeed H; Tibau A; Booth CM; Amir E Cancer; 2019 Nov; 125(22):4069-4075. PubMed ID: 31355923 [TBL] [Abstract][Full Text] [Related]
3. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
4. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors. Mitchell AP; Basch EM; Dusetzina SB JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170 [TBL] [Abstract][Full Text] [Related]
5. Conflicts of interest ethics: silencing expertise in the development of international clinical practice guidelines. Jones DJ; Barkun AN; Lu Y; Enns R; Sinclair P; Martel M; Gralnek I; Bardou M; Kuipers EJ; Sung J; Ann Intern Med; 2012 Jun; 156(11):809-16, W-283. PubMed ID: 22665816 [TBL] [Abstract][Full Text] [Related]
6. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study. Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799 [TBL] [Abstract][Full Text] [Related]
7. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019. Desai AP; Chengappa M; Go RS; Poonacha TK Cancer; 2020 Aug; 126(16):3742-3749. PubMed ID: 32497271 [TBL] [Abstract][Full Text] [Related]
8. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography. Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689 [TBL] [Abstract][Full Text] [Related]
9. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase. Shnier A; Lexchin J; Romero M; Brown K BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247 [TBL] [Abstract][Full Text] [Related]
10. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Choudhry NK; Stelfox HT; Detsky AS JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700 [TBL] [Abstract][Full Text] [Related]
11. Conflict of interest reporting in otolaryngology clinical practice guidelines. Sun GH Otolaryngol Head Neck Surg; 2013 Aug; 149(2):187-91. PubMed ID: 23702973 [TBL] [Abstract][Full Text] [Related]
12. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States. Bansal R; Khan R; Scaffidi MA; Gimpaya N; Genis S; Bukhari A; Dhillon J; Dao K; Bonneau C; Grover SC Gastrointest Endosc; 2020 Feb; 91(2):266-273. PubMed ID: 31738925 [TBL] [Abstract][Full Text] [Related]
13. Guideline funding and conflicts of interest: article 4 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Boyd EA; Akl EA; Baumann M; Curtis JR; Field MJ; Jaeschke R; Osborne M; Schünemann HJ; Proc Am Thorac Soc; 2012 Dec; 9(5):234-42. PubMed ID: 23256165 [TBL] [Abstract][Full Text] [Related]
14. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561 [TBL] [Abstract][Full Text] [Related]
15. Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines. Lu Y; Jones DJ; Sharara N; Kaltenbach T; Laine L; McQuaid K; Soetikno R; Subramanian V; Barkun A PLoS One; 2017; 12(8):e0182856. PubMed ID: 28841650 [TBL] [Abstract][Full Text] [Related]
16. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334 [TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan. Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan. Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027 [TBL] [Abstract][Full Text] [Related]
19. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Benea C; Turner KA; Roseman M; Bero LA; Lexchin J; Turner EH; Thombs BD Syst Rev; 2020 Apr; 9(1):77. PubMed ID: 32268911 [TBL] [Abstract][Full Text] [Related]
20. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]